114 related articles for article (PubMed ID: 38263905)
1. Attenuation of hepatitis A antibody after immunization with hepatitis A vaccine (Aimmugen) in people living with HIV.
Koga M; Saito M; Kubota M; Senkoji T; Adachi E; Ikeuchi K; Kikuchi T; Otani A; Takahashi K; Tsutsumi T; Yotsuyanagi H
Hepatol Res; 2024 May; 54(5):487-494. PubMed ID: 38263905
[TBL] [Abstract][Full Text] [Related]
2. Predictors associated with a better response to the Japanese aluminum-free hepatitis A vaccine, Aimmugen
Koga M; Senkoji T; Kubota M; Ishizaka A; Mizutani T; Sedohara A; Ikeuchi K; Kikuchi T; Adachi E; Saito M; Koibuchi T; Hosomichi K; Ohashi J; Kawana-Tachikawa A; Matano T; Tsutsumi T; Yotsuyanagi H
Hepatol Res; 2022 Mar; 52(3):227-234. PubMed ID: 34825436
[TBL] [Abstract][Full Text] [Related]
3. Impact of frequency and duration of freeze-dried inactivated tissue culture hepatitis A vaccine (Aimmugen®) vaccination on antibody titers; a japanese cross-sectional study.
Maki Y; Edo N; Mizuguchi M; Ikeda M; Kitano M; Kitagami E; Osa M; Yamamoto S; Ogawa T; Nakamura T; Kawana A; Kimizuka Y
Vaccine; 2023 Sep; 41(41):5974-5978. PubMed ID: 37620202
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity of aluminum-adsorbed hepatitis A vaccine (Havrix®) administered as a third dose after primary doses of Japanese aluminum-free hepatitis A vaccine (Aimmugen®) for Japanese travelers to endemic countries.
Fukushima S; Kiyohara T; Ishii K; Nakano T; Hamada A
Vaccine; 2017 Nov; 35(47):6412-6415. PubMed ID: 29029942
[TBL] [Abstract][Full Text] [Related]
5. Delaying the third dose of Japanese aluminum-free hepatitis A vaccine Aimmugen elicits effective immune responses against hepatitis A in adults.
Fukushima S; Kiyohara T; Nakano T; Tada Y; Hamada A
Vaccine; 2023 Jul; 41(32):4726-4730. PubMed ID: 37353455
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of Hepatitis A Immunity and Decision-tree Analysis Among Men Who Have Sex With Men and Are Living With Human Immunodeficiency Virus in Tokyo.
Koibuchi T; Koga M; Kikuchi T; Horikomi T; Kawamura Y; Lim LA; Adachi E; Tsutsumi T; Yotsuyanagi H
Clin Infect Dis; 2020 Jul; 71(3):473-479. PubMed ID: 31504310
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B vaccination uptake and correlates of serologic response among HIV-infected and uninfected men who have sex with men (MSM) in Bangkok, Thailand.
Chonwattana W; Raengsakulrach B; Holtz TH; Wasinrapee P; Tongtoyai J; Chaikummao S; Pattanasin S; McNicholl JM; van Griensven F; Curlin ME
Vaccine; 2016 Apr; 34(17):2044-50. PubMed ID: 26685092
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity and reactogenicity of modified vaccinia Ankara pre-exposure vaccination against mpox according to previous smallpox vaccine exposure and HIV infection: prospective cohort study.
Mazzotta V; Lepri AC; Matusali G; Cimini E; Piselli P; Aguglia C; Lanini S; Colavita F; Notari S; Oliva A; Meschi S; Casetti R; Mondillo V; Vergori A; Bettini A; Grassi G; Pinnetti C; Lapa D; Tartaglia E; Gallì P; Mondi A; Montagnari G; Gagliardini R; Nicastri E; Lichtner M; Sarmati L; Tamburrini E; Mastroianni C; Stingone C; Siddu A; Barca A; Fontana C; Agrati C; Girardi E; Vaia F; Maggi F; Antinori A;
EClinicalMedicine; 2024 Feb; 68():102420. PubMed ID: 38292040
[TBL] [Abstract][Full Text] [Related]
9. High prevalence of anti-hepatitis A IgG in a cohort of UK HIV-negative men who have sex with men: implications for local hepatitis A vaccine policy.
Bhagey A; Foster K; Ralph S; Wardropper A; White C; Wholey V; Duncan S
Int J STD AIDS; 2018 Sep; 29(10):1007-1010. PubMed ID: 29743003
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis E virus seroprevalence and determinants in various study populations in the Netherlands.
Alberts CJ; Schim van der Loeff MF; Sadik S; Zuure FR; Beune EJAJ; Prins M; Snijder MB; Bruisten SM
PLoS One; 2018; 13(12):e0208522. PubMed ID: 30557324
[TBL] [Abstract][Full Text] [Related]
11. Comparative effectiveness of two doses versus three doses of hepatitis A vaccine in human immunodeficiency virus-infected and -uninfected men who have sex with men.
Tseng YT; Chang SY; Liu WC; Sun HY; Wu CH; Wu PY; Lu CL; Hung CC; Chang SC
Hepatology; 2013 May; 57(5):1734-41. PubMed ID: 23258666
[TBL] [Abstract][Full Text] [Related]
12. Antibody response to hepatitis B immunization in infants born to HIV-infected mothers.
Thaithumyanon P; Punnahitananda S; Praisuwanna P; Thisyakorn U; Ruxrungtham K
J Med Assoc Thai; 2002 Mar; 85(3):277-82. PubMed ID: 12117014
[TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Antibody Response Elicited by ChAdOx1 and BNT162b2 COVID-19 Vaccine.
Kang YM; Minn D; Lim J; Lee KD; Jo DH; Choe KW; Kim MJ; Kim JM; Kim KN
J Korean Med Sci; 2021 Nov; 36(46):e311. PubMed ID: 34845875
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal antibody response kinetics following SARS-CoV-2 messenger RNA vaccination in pregnant and nonpregnant persons.
Prabhu M; Yang YJ; Johnston CD; Murphy EA; Ketas TJ; Diaz-Tapia R; Jurkiewicz M; Racine-Brzostek S; Mohammed I; Sukhu AC; Singh S; Forlenza K; Iyer S; Yee J; Eng D; Marks K; Zhao Z; Klasse PJ; Permar S; Moore JP; Riley LE
Am J Obstet Gynecol MFM; 2023 Feb; 5(2):100796. PubMed ID: 36334723
[TBL] [Abstract][Full Text] [Related]
16. Durability of anti-spike antibodies after vaccination with mRNA SARS-CoV-2 vaccine is longer in subjects with previous infection: could the booster dose be delayed?
Stellini R; Gianello R; Gomarasca W
Infection; 2022 Dec; 50(6):1573-1577. PubMed ID: 35391649
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the safety and immunogenicity of live attenuated and inactivated hepatitis A vaccine in healthy Chinese children aged 18 months to 16 years: results from a randomized, parallel controlled, phase IV study.
Ma F; Yang J; Kang G; Sun Q; Lu P; Zhao Y; Wang Z; Luo J; Wang Z
Clin Microbiol Infect; 2016 Sep; 22(9):811.e9-811.e15. PubMed ID: 27345175
[TBL] [Abstract][Full Text] [Related]
18. [Factors Affecting Side Effects, Seroconversion Rates and Antibody Response After Inactivated SARS-CoV-2 Vaccination in Healthcare Workers].
Şenol Akar Ş; Akçalı S; Özkaya Y; Gezginci FM; Cengiz Özyurt B; Deniz G; Karadağ Yalçın F; Özer D; Dündar Erbay P; Eser E
Mikrobiyol Bul; 2021 Oct; 55(4):519-538. PubMed ID: 34666653
[TBL] [Abstract][Full Text] [Related]
19. Seroresponse to SARS-CoV-2 Vaccines among Maintenance Dialysis Patients over 6 Months.
Hsu CM; Weiner DE; Manley HJ; Aweh GN; Ladik V; Frament J; Miskulin D; Argyropoulos C; Abreo K; Chin A; Gladish R; Salman L; Johnson D; Lacson EK
Clin J Am Soc Nephrol; 2022 Mar; 17(3):403-413. PubMed ID: 35144972
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Seropositivity Following BNT162b2 Messenger RNA Vaccination for SARS-CoV-2 in Patients Undergoing Treatment for Cancer.
Massarweh A; Eliakim-Raz N; Stemmer A; Levy-Barda A; Yust-Katz S; Zer A; Benouaich-Amiel A; Ben-Zvi H; Moskovits N; Brenner B; Bishara J; Yahav D; Tadmor B; Zaks T; Stemmer SM
JAMA Oncol; 2021 Aug; 7(8):1133-1140. PubMed ID: 34047765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
